My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 703 / DOI: 10.3332/ecancer.2016.703

Conference Report

Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

After years of trials, Programmed Death Ligand and Receptor targeting finally debuts as a firstline therapy in combination and as a single agent regimen at the 2016 European Society of Medical Oncology (ESMO) Congress. The meeting brought together 20,522 attendees, from over 120 countries, to share updates and novel technologies from a wide swathe of oncology research. This year’s theme, From Disease Treatment to Patient Care, was matched by abstract presentations starting from inception of care regimens to new standards of care in high-risk patient subgroups, to wellbeing of care providers, and finally the funding obstacles at each continental level.

Keywords: ESMO, checkpoint immunotherapy, lung cancer, bladder cancer, ovarian cancer, breast cancer, CDK, fulvestrant, PD-1, PD-L1, PARP inhibition, urothelial cancer

Loading Article Metrics ... Please wait

Related videos

Related articles

Review: Gastric cancer and related epigenetic alterations

Abstract | Full Article | PDF Published: 17 Jan 2017 / DOI: 10.3332/ecancer.2017.714

Research: The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance

Abstract | Full Article | PDF Published: 10 Jan 2017 / DOI: 10.3332/ecancer.2017.711

Conference Report: Balancing health care needs in a changing context: nursing highlights from the 2016 European Oncology Nursing Society Congress (EONS10), 17–18 October 2016, Dublin, Ireland

Abstract | Full Article | PDF Published: 05 Jan 2017 / DOI: 10.3332/ecancer.2017.710

Review: The neutrophil-to-lymphocyte ratio: a narrative review

Abstract | Full Article | PDF Published: 12 Dec 2016 / DOI: 10.3332/ecancer.2016.702

Review: Cancer and the metastatic substrate

Abstract | Full Article | PDF | Spanish Published: 07 Dec 2016 / DOI: 10.3332/ecancer.2016.701



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence